De l'intelligence des données à l'expertise augmentée
0SubscribersSubscribersLog inLog in


ROCHE – Group report and key figures

REPORT’S MAIN STRENGTHS :

  • A report presented through summary slides of group's operations
  • Detailed history of financial performances between 2020 and 2024
  • An overview of the group's major business strategies
  • A medium-term outlook for opportunities and threats
ADD TO BASKET  |  650 €ADD TO BASKET  |  650 €

Collection : Essential

Last update : 30/06/2025

Price : 650 €

Number of pages : 23 pages

Language : English

Format : PDF (immediate availability)

Reference : 25XENT56

DOWNLOAD THE PRESENTATION

IN THIS REPORT
SUMMARY
RELATED REPORTS
DOWNLOAD
THE PRESENTATION
IN THIS REPORT

WHAT IS THE GROUPS' FINANCIAL SITUATION ?

The financial indicators presented in this report include: consolidated revenue, consolidated EBIT and EBIT ratio, consolidated net profit and net profit rate, R&D expenditure and ratio, sales by segment and by region, profitability, liquidity and solvency ratios, free cash flow and capital expenditure.

WHAT ARE THE GROUP'S STRATEGIC PRIORITIES ?

From blockbuster erosion to portfolio renewal

Capitalise on external innovation to enter strategic segments

Lever diagnostics and digital integration


WHAT ARE THE GROUP'S STRENGTHS AND WEAKNESSES ?

Through a SWOT analysis, this report also provides an overview of the group's strengths (leading global pharma player with strong brand and broad geographical presence, etc.) and weaknesses (loss of exclusivity on key biologics (Avastin, Herceptin, Rituxan), etc.).

SUMMARY

1. Overview

Presentation

Segments

SWOT

2. Corporate Strategies and Recent Events

3. Financial Indicators

4. Statistical Appendix

5. Glossary

RELATED REPORTS
RELATED REPORTS
Bayer
30/06/2025 | 23 pages | EN 650 €
façade d'un immeuble de bureaux
Pfizer
30/06/2025 | 23 pages | EN 650 €
building
Sanofi
02/12/2024 | 23 pages | EN 650 €
interior of a building
The Global Pharmaceutical Industry
22/07/2024 | 129 pages | EN 1 950 €
pharmaceutical industry
Johnson & Johnson
15/04/2024 | 23 pages | EN 600 €
vue du ciel depuis les pieds de plusieurs immeubles
Orpéa
23/10/2023 | 23 pages | EN 600 €
orange building

OBTENIR UN EXTRAIT DE CETTE ÉTUDE

╳
Les données collectées serviront uniquement à répondre à votre demande.
En savoir plus sur notre politique de confidentialité.
Envoyer


Merci pour votre intérêt !
Vous allez recevoir dans quelques instants un email contenant le lien pour accéder à l'extrait de l’étude.

ROCHE650 €

30/06/2025 | 23 pages | EN 650 €
PURCHASE
ONLINEPURCHASE
ONLINE PURCHASE
ORDERPURCHASE
ORDER
Purchase
order
Purchase
online

REPORT ADDED TO BASKET

WHY A COOKIE?Continue without accepting >

The XERFI group uses and stores non-sensitive information obtained by placing cookies or equivalent technology on your device. The use of this data allows us to measure our audience and to offer you personalized features and content. We want to ensure that we provide the most informative experience for our visitors.

The data stored by XERFI is not shared with partners or resold to third-parties for advertising purposes. You can give, refuse or withdraw your consent at any time by accessing our cookie page.

ACCEPT

MANAGE CHOICES

EASILY CUSTOMIZE YOUR DATA STORAGE

Google Analytics CookiesThese cookies provide anonymous traffic statistics for the XERFI site in order to optimize its ergonomics, navigation and content.

Visitor journey personalization cookies CookiesThese cookies allow us to provide you with the most relevant content and/or offers of products and services based on your browsing history.

You are free to modify your consent at any time by accessing our cookie setting tool.

VALIDATE CANCEL